BACKGROUND: Base deficit (BD) and lactate are used as markers of mortality, injury severity, and resource utilization in the general trauma population. No study has defined the role of these markers in the triage and management of the normotensive injured elderly patient. METHODS: Retrospective cohort study of the trauma registry from a Level I trauma Center during the period of January 1, 2000 through December 31, 2006. Inclusion criteria were age > or = 65 years, initial systolic blood pressure > or = 90 mm Hg; blunt mechanism of trauma. Lactate was categorized as 0 to 2.4 mmol/L (normal), 2.5 to 4.0 mmol/L (moderately elevated), or > 4.0 mmol/L (severely elevated). BD was categorized as > 0 mEq/L (normal), 0 to -6 mEq/L (moderate), or < -6 mEq/L (severe). The primary outcome was inhospital mortality. RESULTS: Mean lactate was higher in nonsurvivors compared with survivors (2.8 mm/L +/- 1.8 mm/L vs. 2.0 mm/L +/- 1.0 mm/L, p < 0.001). Normal, moderately elevated, and severely elevated lactate was associated with mortality rates of 15% (95% confidence interval [CI] 12-18.8%), 23.4% (95% CI 2-32.4%), and 39.6% (95% CI 26.5-52.8%), respectively. Compared with the normal lactate group, patients in the severely elevated lactate group had 4.2 increased odds of death. BD was more abnormal in nonsurvivors compared with survivors (-2.3 mEq/L +/- 5.2 mEq/L vs. 0.28 mEq/L +/- 1.0 mEq/L, p < 0.001). Normal, moderate, and severe BD were associated with mortality rates of 14% (95% CI 10.3-17.1%), 27% (95% CI 20.1-34.2%), and 40% (95% CI 24.9-54.1%), respectively. Compared with the normal BD group, patients in the severe group had 4.1 increased odds of death. CONCLUSIONS: Both lactate and BD were associated with significantly increased mortality in normotensive elderly blunt trauma patients. However, because of the high baseline mortality rates in elderly trauma patients, "normal" lactate does not offer complete reassurance to the clinician.
BACKGROUND: Base deficit (BD) and lactate are used as markers of mortality, injury severity, and resource utilization in the general trauma population. No study has defined the role of these markers in the triage and management of the normotensive injured elderly patient. METHODS: Retrospective cohort study of the trauma registry from a Level I trauma Center during the period of January 1, 2000 through December 31, 2006. Inclusion criteria were age > or = 65 years, initial systolic blood pressure > or = 90 mm Hg; blunt mechanism of trauma. Lactate was categorized as 0 to 2.4 mmol/L (normal), 2.5 to 4.0 mmol/L (moderately elevated), or > 4.0 mmol/L (severely elevated). BD was categorized as > 0 mEq/L (normal), 0 to -6 mEq/L (moderate), or < -6 mEq/L (severe). The primary outcome was inhospital mortality. RESULTS: Mean lactate was higher in nonsurvivors compared with survivors (2.8 mm/L +/- 1.8 mm/L vs. 2.0 mm/L +/- 1.0 mm/L, p < 0.001). Normal, moderately elevated, and severely elevated lactate was associated with mortality rates of 15% (95% confidence interval [CI] 12-18.8%), 23.4% (95% CI 2-32.4%), and 39.6% (95% CI 26.5-52.8%), respectively. Compared with the normal lactate group, patients in the severely elevated lactate group had 4.2 increased odds of death. BD was more abnormal in nonsurvivors compared with survivors (-2.3 mEq/L +/- 5.2 mEq/L vs. 0.28 mEq/L +/- 1.0 mEq/L, p < 0.001). Normal, moderate, and severe BD were associated with mortality rates of 14% (95% CI 10.3-17.1%), 27% (95% CI 20.1-34.2%), and 40% (95% CI 24.9-54.1%), respectively. Compared with the normal BD group, patients in the severe group had 4.1 increased odds of death. CONCLUSIONS: Both lactate and BD were associated with significantly increased mortality in normotensive elderly blunt traumapatients. However, because of the high baseline mortality rates in elderly traumapatients, "normal" lactate does not offer complete reassurance to the clinician.
Authors: F Murtuza; A J Farrier; M Venkatesan; R Smith; A Khan; C E Uzoigwe; G Chami Journal: Ann R Coll Surg Engl Date: 2015-08-14 Impact factor: 1.891
Authors: Duraid Younan; Chee Paul Lin; Robert Johnson; Robert Clark; Lisa Smith; Jean-Francois Pittet; Mali Mathru; David W Miller Journal: Am J Emerg Med Date: 2018-01-04 Impact factor: 2.469
Authors: Maurizio Cecconi; Glenn Hernandez; Martin Dunser; Massimo Antonelli; Tim Baker; Jan Bakker; Jacques Duranteau; Sharon Einav; A B Johan Groeneveld; Tim Harris; Sameer Jog; Flavia R Machado; Mervyn Mer; M Ignacio Monge García; Sheila Nainan Myatra; Anders Perner; Jean-Louis Teboul; Jean-Louis Vincent; Daniel De Backer Journal: Intensive Care Med Date: 2018-11-19 Impact factor: 17.440
Authors: Noelle Gorgis; Jeannette M Asselin; Cynthia Fontana; R Scott Heidersbach; Heidi R Flori; Shan L Ward Journal: Pediatr Emerg Care Date: 2019-10 Impact factor: 1.454
Authors: Zachary D W Dezman; Angela C Comer; Gordon S Smith; Peter F Hu; Colin F Mackenzie; Thomas M Scalea; Jon Mark Hirshon Journal: Am J Emerg Med Date: 2018-03-07 Impact factor: 2.469
Authors: Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Philip F Stahel; Jean-Louis Vincent; Donat R Spahn Journal: Crit Care Date: 2010-04-06 Impact factor: 9.097
Authors: Jody A Vogel; Nicole Seleno; Emily Hopkins; Christopher B Colwell; Craig Gravitz; Jason S Haukoos Journal: Am J Emerg Med Date: 2015-07-06 Impact factor: 2.469
Authors: Zachary D W Dezman; Angela C Comer; Gordon S Smith; Mayur Narayan; Thomas M Scalea; Jon Mark Hirshon Journal: J Trauma Acute Care Surg Date: 2015-10 Impact factor: 3.313